Trial
NCT04133922
Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Virginia
Collaborators
American Diabetes Association; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Condition
Type 1 Diabetes
Intervention
GLP-1
Why stopped
the study drug could not be obtained
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-22